Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Aspen Pharmacare (APNHY) had Tangible Shareholders Equity of $2.19B for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.44B |
|
-- |
|
$2.75B |
|
$6.41B |
|
$960.52M |
|
$562.22M |
|
$691.34M |
|
$1.65B |
|
-- |
|
|
Tangible Shareholders Equity |
$2.19B |
$4.76B |
|
-- |
|
| Cash Flow Statement Financials | |
$406.64M |
|
$1.44B |
|
$-1.26B |
|
$379.41M |
|
$945.72M |
|
$566.31M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|